Evaluation of neutrophil gelatinase-associated lipocalin (NGAL) as predictor of response to neoadjuvant chemotherapy (NACT) in primary breast cancer.
A. S. Wenners
No relevant relationships to disclose
K. Mehta
No relevant relationships to disclose
S. Loibl
No relevant relationships to disclose
H. Park
No relevant relationships to disclose
N. Arnold
No relevant relationships to disclose
S. Hamann
No relevant relationships to disclose
J. Weimer
No relevant relationships to disclose
B. Ataseven
No relevant relationships to disclose
C. Schem
No relevant relationships to disclose
F. Khandan
No relevant relationships to disclose
C. Thomssen
No relevant relationships to disclose
W. Jonat
No relevant relationships to disclose
H. Holzhausen
No relevant relationships to disclose
G. Von Minckwitz
No relevant relationships to disclose
C. Denkert
No relevant relationships to disclose
M. Bauer
No relevant relationships to disclose